The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $82.34

Today's change+0.82 +1.01%
Updated November 26 4:15 PM EST. Delayed by at least 15 minutes.
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $82.34

Today's change+0.82 +1.01%
Updated November 26 4:15 PM EST. Delayed by at least 15 minutes.

Express Scripts Holding Co Hits New 52-week High

Express Scripts Holding Co closed up Wednesday by (U.S.)$0.82 or 1.01% to (U.S.)$82.34 and setting a new 52-week high. Over the last five days, shares have gained 3.61% and 17.23% year to date. Shares have outperformed the S&P 500 by 7.72% during the last year.

Key company metrics

  • Open(U.S.) $81.65
  • Previous close(U.S.) $81.52
  • High(U.S.) $82.38
  • Low(U.S.) $81.35
  • Bid / Ask-- / --
  • YTD % change+17.23%
  • Volume2,978,945
  • Average volume (10-day)3,672,047
  • Average volume (1-month)3,833,085
  • Average volume (3-month)3,684,729
  • 52-week range(U.S.) $64.64 to (U.S.) $82.38
  • Beta1.19
  • Trailing P/E32.73×
  • P/E 1 year forward16.87×
  • Forward PEG1.37×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.52
Updated November 26 4:15 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.96%

Based on its net profit margin of 1.96%, Express Scripts Holding Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue25,77925,11123,68525,781
Total other revenue--------
Total revenue25,77925,11123,68525,781
Gross profit2,0732,0081,7502,061
Total cost of revenue23,70623,10321,93523,720
Total operating expense24,79424,14522,97624,953
Selling / general / administrative1,0891,0421,0411,232
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income984966709829
Interest income (expense), net non-operating-202-135-125-126
Gain (loss) on sale of assets--------
Other--------
Income before tax798842596726
Income after tax589523335518
Income tax, total209319261208
Net income582515328502
Total adjustments to net income--------
Net income before extra. items582515328514
Minority interest-7-8-6-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items582515328514
Inc. avail. to common incl. extra. items582515328502
Diluted net income582515328502
Dilution adjustment--------
Diluted weighted average shares746767786797
Diluted EPS excluding extraordinary itemsvalue per share0.780.670.420.65
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.780.670.420.65